AKRO icon

Akero Therapeutics
AKRO

Overview Fund Activity

173 hedge funds and large institutions have $1.85B invested in Akero Therapeutics in 2024 Q1 according to their latest regulatory filings, with 37 funds opening new positions, 74 increasing their positions, 45 reducing their positions, and 21 closing their positions.

Holders
173
Holders Change
+16
Holders Change %
+10.19%
% of All Funds
2.51%
Holding in Top 10
4
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+100%
% of All Funds
0.06%
New
37
Increased
74
Reduced
45
Closed
21
Calls
$15.3M
Puts
$20M
Net Calls
-$4.78M
Net Calls Change
-$34.4M

Top Buyers

1
GA
1
General Atlantic
New York
$132M
2
Wellington Management Group
2
Wellington Management Group
Massachusetts
$132M
3
RI
3
RTW Investments
New York
$137M
4
Janus Henderson Group
4
Janus Henderson Group
United Kingdom
$155M
5
FAM
5
Fred Alger Management
New York
$33.8M

Top Sellers

1
Morgan Stanley
1
Morgan Stanley
New York
$10.2M
2
State Street
2
State Street
Massachusetts
$95.9M
3
CC
3
Commodore Capital
New York
$0
4
YCM
4
Yiheng Capital Management
California
$36.2M
5
Alkeon Capital Management
5
Alkeon Capital Management
New York
$84M
Name Market Value Shares Shares
Change 		Shares
Change %
Charles Schwab
26
Charles Schwab
California
$13.1M 518,286 +92,741 +22%
Bank of America
27
Bank of America
North Carolina
$10.8M 425,871 -63,770 -13%
EMFAT
28
Emerald Mutual Fund Advisers Trust
Pennsylvania
$10.7M 424,901 +308,820 +266%
Citadel Advisors
29
Citadel Advisors
Florida
$10.6M 419,660 -65,365 -13%
D.E. Shaw & Co
30
D.E. Shaw & Co
New York
$10.3M 407,125 +196,165 +93%
Morgan Stanley
31
Morgan Stanley
New York
$10.2M 403,863 -1,710,791 -81%
SCM
32
Silverarc Capital Management
Massachusetts
$10.1M 399,949 +150,695 +60%
UOWF
33
University of Wisconsin Foundation
Wisconsin
$9.41M 372,575 – –
OCA
34
Octagon Capital Advisors
New York
$8.59M 340,000 +340,000 New
MB
35
MPM BioImpact
Massachusetts
$8.41M 332,924 +332,924 New
LFCM
36
Long Focus Capital Management
Puerto Rico
$8.3M 328,604 -181,396 -36%
PBM
37
Propel Bio Management
California
$8.28M 327,752 +227,700 +228%
Deutsche Bank
38
Deutsche Bank
Germany
$8.25M 326,755 +136,544 +72%
JPMorgan Chase & Co
39
JPMorgan Chase & Co
New York
$8.22M 325,399 +172,521 +113%
Artisan Partners
40
Artisan Partners
Wisconsin
$7.68M 303,920 – –
Rafferty Asset Management
41
Rafferty Asset Management
New York
$7.43M 294,113 -157,719 -35%
Point72 Asset Management
42
Point72 Asset Management
Connecticut
$7.3M 289,106 -355,199 -55%
Citigroup
43
Citigroup
New York
$6.45M 255,434 +66,982 +36%
Jane Street
44
Jane Street
New York
$6.32M 250,075 -5,474 -2%
SAM
45
Simplify Asset Management
Nevada
$6.21M 245,676 +185,899 +311%
CS
46
Candriam SCA
Luxembourg
$6.06M 240,000 +56,000 +30%
Ensign Peak Advisors
47
Ensign Peak Advisors
Utah
$5.87M 232,544 -720 -0.3%
UBS Group
48
UBS Group
Switzerland
$5.25M 208,001 -58,385 -22%
Aberdeen Group
49
Aberdeen Group
United Kingdom
$5.03M 199,237 +127,695 +178%
Bank of New York Mellon
50
Bank of New York Mellon
New York
$4.78M 189,246 +11,451 +6%
1
2
3 4 5